Karwaciak I, Karas K, Salkowska A, Pastwinska J, Ratajewski M
Molecules. 2022; 27(12).
PMID: 35744777
PMC: 9228867.
DOI: 10.3390/molecules27123651.
Xu F, Xi H, Liao M, Zhang Y, Ma H, Wu M
Cancer Chemother Pharmacol. 2022; 89(3):331-346.
PMID: 35067737
DOI: 10.1007/s00280-021-04386-z.
Won E, Na K, Kim Y
Int J Mol Sci. 2022; 23(1).
PMID: 35008730
PMC: 8745430.
DOI: 10.3390/ijms23010305.
Wang C, Yang H, Huang H, Hsiao C, Jiu B, Lin C
Acta Cardiol Sin. 2021; 37(2):195-203.
PMID: 33716462
PMC: 7953112.
DOI: 10.6515/ACS.202103_37(2).20200907A.
Hoertel N, Sanchez-Rico M, Vernet R, Jannot A, Neuraz A, Blanco C
Clin Drug Investig. 2021; 41(3):221-233.
PMID: 33559821
PMC: 7871023.
DOI: 10.1007/s40261-021-01001-0.
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment.
Muric N, Arsenijevic N, Borovcanin M
Front Psychiatry. 2021; 11:612347.
PMID: 33424669
PMC: 7785719.
DOI: 10.3389/fpsyt.2020.612347.
Repurposing chlorpromazine to treat COVID-19: The reCoVery study.
Plaze M, Attali D, Petit A, Blatzer M, Simon-Loriere E, Vinckier F
Encephale. 2020; 46(3):169-172.
PMID: 32425222
PMC: 7229964.
DOI: 10.1016/j.encep.2020.05.006.
[Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
Plaze M, Attali D, Petit A, Blatzer M, Simon-Loriere E, Vinckier F
Encephale. 2020; 46(3S):S35-S39.
PMID: 32387014
PMC: 7188634.
DOI: 10.1016/j.encep.2020.04.010.
The Neuroscience of Nonpharmacological Traditional Chinese Therapy (NTCT) for Major Depressive Disorder: A Systematic Review and Meta-Analysis.
Ye J, Cheung W, Tsang H
Evid Based Complement Alternat Med. 2019; 2019:2183403.
PMID: 31223326
PMC: 6541968.
DOI: 10.1155/2019/2183403.
Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression.
Won E, Kim Y
Curr Neuropharmacol. 2016; 14(7):665-73.
PMID: 27640517
PMC: 5050399.
DOI: 10.2174/1570159x14666151208113006.
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.
Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain S
World J Biol Psychiatry. 2016; 18(3):162-214.
PMID: 27419272
PMC: 5341771.
DOI: 10.1080/15622975.2016.1190867.
Phenoxybenzamine in complex regional pain syndrome: potential role and novel mechanisms.
Inchiosa Jr M
Anesthesiol Res Pract. 2014; 2013:978615.
PMID: 24454356
PMC: 3880724.
DOI: 10.1155/2013/978615.
Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication.
Schmitt A, Bertsch T, Tost H, Bergmann A, Henning U, Klimke A
Neuropsychiatr Dis Treat. 2008; 1(2):171-7.
PMID: 18568063
PMC: 2413198.
DOI: 10.2147/nedt.1.2.171.61048.
The effects of dexamethasone and chlorpromazine on tumour necrosis factor-alpha, interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-10 in human volunteers.
Bleeker M, Netea M, Kullberg B, van der Ven-Jongekrijg J, van der Meer J
Immunology. 1997; 91(4):548-52.
PMID: 9378493
PMC: 1363874.
DOI: 10.1046/j.1365-2567.1997.00285.x.
The role of enteric bacteria in the pathogenesis of fatal cycloheximide intolerance in mice pretreated with dexamethasone, promethazine or nordihydroguaiaretic acid.
PARRY E
Inflamm Res. 1996; 45(7):354-6.
PMID: 8841837
DOI: 10.1007/BF02252948.
Chlorpromazine specifically inhibits peripheral and brain TNF production, and up-regulates IL-10 production, in mice.
Mengozzi M, Fantuzzi G, Faggioni R, Marchant A, Goldman M, Orencole S
Immunology. 1994; 82(2):207-10.
PMID: 7927490
PMC: 1414809.